Stay updated on Seladelpar in Primary Biliary Cholangitis Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.

Latest updates to the Seladelpar in Primary Biliary Cholangitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed notices about government funding lapse and operating status (v3.4.1). These changes do not affect the study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice about funding and operations was added, and the page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a visible glossary and a No FEAR Act Data notice. Updated the QC field label to 'Last Update Submitted that Met QC Criteria' and bumped the revision to v3.4.0, replacing v3.3.4 entries.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and revision: v3.3.3 was removed, indicating an administrative page update, with no impact on study details, eligibility criteria, outcomes, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA centralized Locations section is added and populated with study sites across the United States and Canada. The page version is updated to v3.3.3 and the HHS Vulnerability Disclosure link is removed.SummaryDifference1%

- Check92 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the revision has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Seladelpar in Primary Biliary Cholangitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in Primary Biliary Cholangitis Clinical Trial page.